Stocks · Health care · Pharmaceutical Preparations

Cartesian Therapeutics, Inc.

RNAC Clue Score28

United States Fiscal year ends December CIK 0001453687 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

34 insiders · 244 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Timothy A Springer

Director

$78.22M (84)

—

+$78.22M

30,089,219

99.45%

$205.20M

—

Amir Nashat

Director

$1.75M (4)

$5.77M (20)

−$4.02M

2,676,234

8.85%

$18.25M

+48.2%

Edwin Kania

Director

—

$3.74M (1)

−$3.74M

586,595

1.94%

$4.00M

−31.3%

Metin Kurtoglu

Chief Technology Officer

—

$2.51M (14) scheduled

−$2.51M

62,258

0.2058%

$424.58K

—

Lloyd P. Johnston

Chief Operations Officer

—

$975.83K (14) scheduled

−$975.83K

265,515

0.8776%

$1.81M

+5,665%

Milos Miljkovic

Chief Medical Officer

—

$963.44K (5) scheduled

−$963.44K

58,820

0.1944%

$401.13K

—

Christopher M Jewell

Chief Scientific Officer

—

$917.82K (5) scheduled

−$917.82K

62,490

0.2065%

$426.16K

—

Carsten Brunn

President and CEO

—

$836.46K (24)

−$836.46K

323,530

1.07%

$2.21M

—

David Siewers

CFO and Treasurer

—

$807.65K (6) scheduled

−$807.65K

0

0.0000%

$0.00

−100.0%

Timothy C Barabe

Director

$574.79K (10)

—

+$574.79K

56,966

0.1883%

$388.49K

—

Peter G Traber

Chief Medical Officer

$358.47K (6)

$52.05K (8)

+$306.42K

451,826

1.49%

$3.08M

+3,424%

Takashi Kei Kishimoto

Chief Scientific Officer

—

$227.26K (8) scheduled

−$227.26K

225,316

0.7447%

$1.54M

+1,116%

David Abraham

GC, CCO & Corporate Secretary

$50.00K (1)

$267.19K (1) scheduled

−$217.20K

5,405

0.0179%

$36.86K

+110.8%

Blaine Davis

Chief Financial Officer

—

$206.26K (3)

−$206.26K

121,220

0.4007%

$826.68K

—

Carrie Smith Cox

Director

$200.46K (2)

—

+$200.46K

15,629

0.0517%

$106.59K

—

Werner Cautreels

President and CEO

$186.25K (1)

—

+$186.25K

321,203

1.06%

$2.19M

+6.6%

Peter Keller

Chief Business Officer

—

$176.43K (2) scheduled

−$176.43K

405

0.0013%

$2.76K

−92.1%

Omid Farokhzad

Director

$125.00K (1)

—

+$125.00K

271,337

0.8968%

$1.85M

+112.0%

Earl Sands

Chief Medical Officer

$76.97K (1)

—

+$76.97K

7,500

0.0248%

$51.15K

—

Emily English

Chief Operations Officer

—

$30.15K (2)

−$30.15K

94,226

0.3114%

$642.59K

+415.7%

Nishan M DeSilva

Director

$20.72K (1)

—

+$20.72K

11,366

0.0376%

$77.51K

—

Kevin Tan

Chief Financial Officer

$15.13K (1)

—

+$15.13K

77,000

0.2545%

$525.12K

—

Murat Kalayoglu

10% owner

—

—

—

5,824,838

19.25%

$39.72M

—

Elizabeth Hoge

10% owner

—

—

—

5,313,261

17.56%

$36.23M

—

Elona Kogan

General Counsel

—

—

—

182,872

0.6044%

$1.25M

—

Aymeric Sallin

Director

—

—

—

178,000

0.5883%

$1.21M

—

Michael Singer

Director

—

—

—

145,797

0.4819%

$994.29K

—

Scott Dunseth Myers

Director

—

—

—

80,845

0.2672%

$551.34K

—

Bradford D. Dahms

Chief Financial Officer

—

—

—

38,000

0.1256%

$259.15K

—

Stephen Smolinski

Chief Commercial Officer

—

—

—

13,812

0.0457%

$94.19K

—

Patrick J Zenner

Director

—

—

—

12,974

0.0429%

$88.48K

—

Kemal Malik

Director

—

—

—

11,133

0.0368%

$75.92K

—

June Ann Seymour

Chief Accounting Officer

—

—

—

6,500

0.0215%

$44.33K

—

Adrian Ion Bot

Director

—

—

—

5,800

0.0192%

$39.55K

—